Variable | Total (n = 1854) | DLI(n = 336) | Non-DLI(n = 1518) | p value |
---|---|---|---|---|
Follow-up in months, mean (SD) | 92.9 ± 51.5 | 89.59 ± 53.7 | 93.7 ± 51.0 | 0.209 |
5-year overall survival, % | 92.0% (90.5 − 93.4%) | 89.0% (85.0 − 93.0%) | 92.6% (91.1 − 94.2%) | 0.064 |
5-year disease-free survival, % | 67.3% (64.7 − 69.9%) | 51.2% (44.4 − 57.9%) | 70.7% (67.9 − 73.5%) | <0.001* |
5-year distant relapse-free survival, % | 71.2% (68.5 − 73.8%) | 57.4% (50.3 − 64.5%) | 73.9% (71.1 -76.6%) | <0.001* |
5-year local recurrence-free survival, % | 85.8% (83.6 − 88.0%) | 71.7% (64.5 − 79.0%) | 88.5% (86.3 − 90.7%) | 0.018* |